Legal DealFolio - BioAmber - Initial Public Offering on the NYSE

SJ Berwin advised BioAmber, a sustainable chemicals company on its Initial Public Offering on the NYSE and the simultaneous listing of its common stock on the professional segment of Euronext Paris. BioAmber is the first US company to use Euronext's Fast Path process in the context of its Initial Public Offering on its original market. The offering raised a total of USD80 million, valuing the company at USD180 million. Following trading of units on the NYSE for a 30 day period, BioAmber's common stock began trading in US dollars on the NYSE on 10 June 2013 and in euros on Euronext Paris on 11 June 2013. Credit Suisse, Barclays and Societe Generale acted as joint book-running managers for the offering. Pacific Crest Securities acted as co-manager for the offering. Founded in 2008, BioAmber is a sustainable chemicals company. Its proprietary technology platform combines industrial biotechnology, an innovative purification process and chemical catalysis to convert renewable raw materials into sustainable chemicals for use in a wide variety of everyday products. With the proceeds from the offering, BioAmber plans to build a world-scale bio-succinic acid manufacturing facility in Sarnia with 30,000 ton annual capacity. Advisors on French legal matters: SJ Berwin, advisor to the issuer: Etienne Boursican and Pierre-Louis Perin, partners, Edouard Balades, Marco Toracca, associates (corporate); Raphael Bera, partner, Sarah Mordoff, associate (tax).

Deal Date:	12-06-2013	Practice Area:	Equity Capital Markets
Deal Title:	BioAmber - Initial Public Offering on the NYSE	Industry:	Chemicals
Description:	SJ Berwin advised BioAmber, a sustainable chemicals company on its Initial Public Offering on the NYSE and the simultaneous listing of its common stock on the professional segment of Euronext Paris. BioAmber is the first US company to use Euronext's Fast Path process in the context of its Initial Public Offering on its original market. The offering raised a total of USD80 million, valuing the company at USD180 million. Following trading of units on the NYSE for a 30 day period, BioAmber's common stock began trading in US dollars on the NYSE on 10 June 2013 and in euros on Euronext Paris on 11 June 2013. Credit Suisse, Barclays and Societe Generale acted as joint book-running managers for the offering. Pacific Crest Securities acted as co-manager for the offering. Founded in 2008, BioAmber is a sustainable chemicals company. Its proprietary technology platform combines industrial biotechnology, an innovative purification process and chemical catalysis to convert renewable raw materials into sustainable chemicals for use in a wide variety of everyday products. With the proceeds from the offering, BioAmber plans to build a world-scale bio-succinic acid manufacturing facility in Sarnia with 30,000 ton annual capacity. Advisors on French legal matters: SJ Berwin, advisor to the issuer: Etienne Boursican and Pierre-Louis Perin, partners, Edouard Balades, Marco Toracca, associates (corporate); Raphael Bera, partner, Sarah Mordoff, associate (tax).
Financial Center:	Paris	Value:	0.00-100.00
Advised Party:	Issuer	Law Firm	King & Wood Mallesons SJ Berwin
Issuer Jurisdiction-	France	Listing Jurisdiction-	United States
Classification:	Initial Public Offerings NYSE	Lawyer	Pierre-Louis Perin

Practice Areas -

Equity Capital Markets Law Firms and Lawyers

Practice Areas - Equity Capital Markets Law Firms and Lawyers